Brexpiprazole (OPC 34712) Trial in the Treatment of Adults With Major Depressive Disorder and Irritability

Withdrawn before enrolling · Phase 3

Conditions studied: Major Depressive Disorder and Irritability

In brief

The purpose of this study is to explore the effects of fixed-dosed brexpiprazole adjunctive treatment in subjects with Major Depressive Disorder with irritability

Key facts

Study ID

NCT02212613

Run by

Otsuka Pharmaceutical Development & Commercialization, Inc.

People needed

0

Starts

2014-09-01

Expected to finish

2015-11-01

Last updated by the study team

2016-07-07

Who can join

Age: 18 and older, up to 55. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Emory University — Atlanta, Georgia, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.